+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cell Reprogramming Market Size, Share & Trends Analysis Report by Technology (Episomal Reprogramming, mRNA Reprogramming), Application (Therapeutic, Research), End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 119 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 5649372
Description Jump to:
The global cell reprogramming market size is expected to reach USD 664.2 million by 2030, according to the report., growing at a CAGR of 8.52% from 2024 to 2030. Factors, such as increasing adoption of cell reprogramming in cancer research and growing focus on cell reprogramming, are expected to drive market growth. In addition, emphasis on collaborations and partnerships among key players is anticipated to boost market growth. Advancements in the mRNA reprogramming technique allow rapid, safe, and efficient generation of clinical-grade human iPS cells using somatic tissue. In addition, as mRNA is lower in size, the transfection process is simpler than other reprogramming vectors. When utilizing difficult-to-reprogram samples, mRNA reprogramming improves reprogramming efficiency by 1%.

Furthermore, this method can generate high-quality human iPS cells from somatic tissue more rapidly and safely, which increases the demand for mRNA reprogramming technology. Furthermore, there is the capability to reprogram human stem cells back to a naive state, allowing replication of the earliest developmental stages. For instance, in March 2022, researchers at the Babraham Institute identified key factors facilitating this reprogramming process. This new knowledge streamlines and expedites the generation of naive pluripotent stem cells for researchers. Moreover, cell reprogramming is experiencing growth due to significant government and public funding. This backing is a response to various benefits it offers to the healthcare sector, particularly in terms of its potential applications in medicine.

Furthermore, cell reprogramming has recently been repositioned from the lab to clinic by researchers. This shift is prominent in various clinical & academic research initiatives, encompassing regenerative medicine, disease modeling, and studies related to medication toxicity & drug discovery. The clinical utility of cell reprogramming, especially in regenerative medicine, has been significant. Increased strategic initiatives aimed at innovative product development through cell reprogramming is due to a growth in the research and academic institute segment. For instance, the California Institute for Regenerative Medicine funded research groups to advance cellular reprogramming into therapeutic applications with a clinical focus.

Cell Reprogramming Market Report Highlights

  • The mRNA reprogramming technology segment held the largest revenue share of 32.67% in 2023 due to the ease of use, speed, safety, and efficiency while generating high-quality human iPS cells from somatic tissue
  • The research application segment led the market with a share of 67.41% in 2023. One of the main factors driving its growth include ongoing research in the field of cell reprogramming using stem cells
  • The research & academic institute end-use segment held a revenue share of 67.41% in 2023. The growth is due to usage of cell reprogramming in a various clinical & academic research initiatives, including those involving regenerative therapies, disease modeling, and drug toxicity/drug discovery studies
  • North America dominated the global industry in 2023 with a revenue share of 38.65% owing to the presence of key players in this region

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Platform & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Platform & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing focus on cell reprogramming
3.2.1.2. Increasing adoption of cell reprogramming in cancer research
3.2.1.3. Emphasis on collaborations and partnerships among key players
3.2.2. Market Restraint Analysis
3.2.2.1. Challenges associated with iPSCs
3.2.2.2. Limited awareness regarding treatment option
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Technology Business Analysis
4.1. Cell Reprogramming Market: Technology Movement Analysis
4.2. Sendai Virus-based Reprogramming
4.2.1. Sendai Virus-based Reprogramming Market, 2018 - 2030 (USD Million)
4.3. mRNA Reprogramming
4.3.1. mRNA Reprogramming Market, 2018 - 2030 (USD Million)
4.4. Episomal Reprogramming
4.4.1. Episomal Reprogramming Market, 2018 - 2030 (USD Million)
4.5. Others
4.5.1. Others Reprogramming Market, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Cell Reprogramming Market: Application Movement Analysis
5.2. Research
5.2.1. Research Market, 2018 - 2030 (USD Million)
5.3. Therapeutics
5.3.1. Therapeutics Market, 2018 - 2030 (USD Million)
Chapter 6. End-use Business Analysis
6.1. Cell Reprogramming Market: End-use Movement Analysis
6.2. Research & Academic Institutes
6.2.1. Research & Academic Institutes Market, 2018 - 2030 (USD Million)
6.3. Biotechnology & Pharmaceutical Companies
6.3.1. Biotechnology & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Cell Reprogramming Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. North America Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. U.S. Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Canada Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. UK Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Germany Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. France Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Italy Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Spain Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Denmark Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Sweden Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Norway Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Japan Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. China Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. India Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Australia Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Thailand Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. South Korea Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Brazil Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Mexico Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Argentina Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. South Africa Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Saudi Arabia Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. UAE Cell Reprogramming Market, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Kuwait Cell Reprogramming Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Allele Biotech
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. ALSTEM
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. STEMCELL Technologies Inc.
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Merck KGaA
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Bio-Techne
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. REPROCELL
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Lonza
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. FUJIFILM Corporation (Fujifilm Cellular Dynamics)
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Mogrify Limited
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 4 Global Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 5 Global Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 6 Global Cell Reprogramming Market, By Region, 2018 - 2030 (USD Million)
Table 7 North America Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
Table 8 North America Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 9 North America Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 10 North America Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 11 U.S. Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 12 U.S. Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 13 U.S. Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 14 Canada Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 15 Canada Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 16 Canada Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 17 Europe Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
Table 18 Europe Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 19 Europe Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 20 Europe Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 21 UK Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 22 UK Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 23 UK Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 24 Germany Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 25 Germany Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 26 Germany Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 27 France Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 28 France Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 29 France Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 30 Spain Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 31 Spain Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 32 Spain Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 33 Italy Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 34 Italy Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 35 Italy Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 36 Denmark Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 37 Denmark Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 38 Denmark Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 39 Norway Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 40 Norway Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 41 Norway Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 42 Sweden Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 43 Sweden Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 44 Sweden Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 49 China Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 50 China Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 51 China Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 52 Japan Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 53 Japan Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 54 Japan Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 55 India Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 56 India Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 57 India Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 58 South Korea Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 59 South Korea Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 60 South Korea Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 61 Australia Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 62 Australia Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 63 Australia Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 64 Thailand Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 65 Thailand Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 66 Thailand Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 67 Latin America Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
Table 68 Latin America Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 69 Latin America Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 70 Latin America Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 71 Brazil Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 72 Brazil Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 73 Brazil Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 74 Mexico Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 75 Mexico Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 76 Mexico Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 77 Argentina Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 78 Argentina Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 79 Argentina Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 80 MEA Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
Table 81 MEA Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 82 MEA Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 83 MEA Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 84 South Africa Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 85 South Africa Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 86 South Africa Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 87 UAE Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 88 UAE Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 89 UAE Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 90 Saudi Arabia Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 91 Saudi Arabia Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 92 Saudi Arabia Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
Table 93 Kuwait Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
Table 94 Kuwait Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
Table 95 Kuwait Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Cell Reprogramming market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s five forces analysis
Fig. 14 Global cell reprogramming market: Technology outlook and key takeaways
Fig. 15 Global cell reprogramming market: Technology movement analysis
Fig. 16 Global cell reprogramming market, for sendai virus-based reprogramming, 2018 - 2030 (USD Million)
Fig. 17 Global cell reprogramming market, for mRNA reprogramming, 2018 - 2030 (USD Million)
Fig. 18 Global cell reprogramming market, for episomal reprogramming, 2018 - 2030 (USD Million)
Fig. 19 Global cell reprogramming market, for others, 2018 - 2030 (USD Million)
Fig. 20 Global cell reprogramming market: Application outlook and key takeaways
Fig. 21 Global cell reprogramming market: Application movement analysis
Fig. 22 Global cell reprogramming market, for research, 2018 - 2030 (USD Million)
Fig. 23 Global cell reprogramming market, for therapeutic, 2018 - 2030 (USD Million)
Fig. 24. Global cell reprogramming market: End-use outlook and key takeaways
Fig. 25 Global cell reprogramming market: End-use movement analysis
Fig. 26 Global cell reprogramming market, for research & academic institutes, 2018 - 2030 (USD Million)
Fig. 27 Global cell reprogramming market, for biotechnology & pharmaceutical companies, 2018 - 2030 (USD Million)
Fig. 28 Regional marketplace: Key takeaways
Fig. 29 Regional outlook, 2022 & 2030
Fig. 30 North America cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 31 U.S. Key country dynamics
Fig. 32 U.S. cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 33 Canada Key country dynamics
Fig. 34 Canada cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 35 Europe cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 36 Germany Key country dynamics
Fig. 37 Germany cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 38 UK Key country dynamics
Fig. 39 UK cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 40 France Key country dynamics
Fig. 41 France cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 42 Italy Key country dynamics
Fig. 43 Italy cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 44 Spain Key country dynamics
Fig. 45 Spain cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 46 Denmark Key country dynamics
Fig. 47 Denmark cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 48 Sweden Key country dynamics
Fig. 49 Sweden cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 50 Norway Key country dynamics
Fig. 51 Norway cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 52 Asia Pacific cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 53 Japan Key country dynamics
Fig. 54 Japan cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 55 China Key country dynamics
Fig. 56 China cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 57 India Key country dynamics
Fig. 58 India cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 59 Australia Key country dynamics
Fig. 60 Australia cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 61 South Korea Key country dynamics
Fig. 62 South Korea cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 63 Thailand Key country dynamics
Fig. 64 Thailand cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 65 Latin America cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 66 Brazil Key country dynamics
Fig. 67 Brazil cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 68 Mexico Key country dynamics
Fig. 69 Mexico cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 70 Argentina Key country dynamics
Fig. 71 Argentina cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 72 Middle East and Africa cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 73 South Africa Key country dynamics
Fig. 74 South Africa cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 75 Saudi Arabia Key country dynamics
Fig. 76 Saudi Arabia cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 77 UAE Key country dynamics
Fig. 78 UAE cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 79 Kuwait Key country dynamics
Fig. 80 Kuwait cell reprogramming market, 2018 - 2030 (USD Million)

Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • Allele Biotech
  • ALSTEM
  • STEMCELL Technologies Inc.
  • Merck KGaA
  • Bio-Techne
  • REPROCELL
  • Lonza
  • FUJIFILM Corporation (Fujifilm Cellular Dynamics)
  • Mogrify Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages119
PublishedNovember 2023
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 375.3 Million
Forecasted Market Value ( USD ) by 2030 $ 664.2 Million
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Cell Reprogramming Market by Technology (Episomal Reprogramming, mRNA Reprogramming, Sendai Virus-Based Reprogramming), Application (Research, Therapeutic), End-Use - Forecast 2024-2030 - Product Image

Global Cell Reprogramming Market by Technology (Episomal Reprogramming, mRNA Reprogramming, Sendai Virus-Based Reprogramming), Application (Research, Therapeutic), End-Use - Forecast 2024-2030

  • Report
  • 182 Pages
  • Global
From
Cell Reprogramming Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Image

Cell Reprogramming Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • 178 Pages
  • Global
From
Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 200 Pages
  • Global
From
Chemical Biology in Regenerative Medicine. Bridging Stem Cells and Future Therapies. Edition No. 1 - Product Image

Chemical Biology in Regenerative Medicine. Bridging Stem Cells and Future Therapies. Edition No. 1

  • Book
  • 240 Pages
Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts, 2023 - Product Image

Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts, 2023

  • Report
  • 326 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.